Literature DB >> 20012110

Modulation of motorcortical excitability by methylphenidate in adult voluntary test persons performing a go/nogo task.

Johannes Buchmann1, A Dueck, W Gierow, H Zamorski, S Heinicke, H Heinrich, J Hoeppner, T Klauer, O Reis, F Haessler.   

Abstract

This study investigated the interaction between motorcortical excitability (short interval cortical inhibition, intracortical facilitation and long interval cortical inhibition), different requirement conditions [choice reaction test (CRT), attention/go/nogo], and their pharmacological modulation by methylphenidate (MPH) in normal healthy adults (n = 31) using a transcranial magnetic stimulation paradigm. MPH was administered in a dosage of 1 mg/kg body weight, maximum 60 mg. Additionally, serum level and clearance of MPH were controlled. The statistical analysis of variance revealed a significant three-way interaction of 2 (MPH) x 3 (CRT) x 6 (ISI) predicting motor evoked potential amplitudes (P = 0.032, MPH none and full dose, n = 31). In order to compare effects of dosage an additional between-subjects factor (half vs. full MPH dose) was introduced. None of the interactions involving this between-subject factor reached statistical significance. Exploring interactions with MPH only, a 3 (MPH none, half and full dose) x 3 (CRT) x 6 (ISI) analysis of variance revealed significant two-way interactions for MPH x ISI (P = 0.040) and condition x ISI (P < 0.001, n = 18). Effects observed for MPH were strongest on facilitatory processes, weaker for intracortical inhibition. In sum, MPH seems to interact via striato-thalamo-cortical pathways with original motorcortical processes (ISI), to a lesser extent with task-dependent or behavioral parameters (CRT).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20012110     DOI: 10.1007/s00702-009-0349-z

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  70 in total

1.  Interactions between two different inhibitory systems in the human motor cortex.

Authors:  T D Sanger; R R Garg; R Chen
Journal:  J Physiol       Date:  2001-01-15       Impact factor: 5.182

2.  Human cortical activities during Go/NoGo tasks with opposite motor control paradigms.

Authors:  Kentaro Yamanaka; Toshitaka Kimura; Makoto Miyazaki; Noritaka Kawashima; Daichi Nozaki; Kimitaka Nakazawa; Hideo Yano; Yoshiharu Yamamoto
Journal:  Exp Brain Res       Date:  2001-11-29       Impact factor: 1.972

Review 3.  Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions.

Authors:  Amy F T Arnsten; Bao-Ming Li
Journal:  Biol Psychiatry       Date:  2005-06-01       Impact factor: 13.382

4.  The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability.

Authors:  J B Williams; M Gibbon; M B First; R L Spitzer; M Davies; J Borus; M J Howes; J Kane; H G Pope; B Rounsaville
Journal:  Arch Gen Psychiatry       Date:  1992-08

5.  Higher anticipated force required a stronger inhibitory process in go/nogo tasks.

Authors:  Hiroki Nakata; Koji Inui; Toshiaki Wasaka; Yohei Tamura; Kosuke Akatsuka; Tetsuo Kida; Ryusuke Kakigi
Journal:  Clin Neurophysiol       Date:  2006-06-22       Impact factor: 3.708

6.  Stop and go: the neural basis of selective movement prevention.

Authors:  James P Coxon; Cathy M Stinear; Winston D Byblow
Journal:  J Cogn Neurosci       Date:  2009-06       Impact factor: 3.225

7.  Responses to paired transcranial magnetic stimuli in resting, active, and recently activated muscles.

Authors:  E M Wassermann; A Samii; B Mercuri; K Ikoma; D Oddo; S E Grill; M Hallett
Journal:  Exp Brain Res       Date:  1996-04       Impact factor: 1.972

8.  Transcranial magnetic stimulation-evoked cortical inhibition: a consistent marker of attention-deficit/hyperactivity disorder scores in tourette syndrome.

Authors:  Donald L Gilbert; Floyd R Sallee; Jie Zhang; Tara D Lipps; Eric M Wassermann
Journal:  Biol Psychiatry       Date:  2005-06-15       Impact factor: 13.382

9.  Enantioselective pharmacokinetics of dl-threo-methylphenidate in humans.

Authors:  N R Srinivas; J W Hubbard; E D Korchinski; K K Midha
Journal:  Pharm Res       Date:  1993-01       Impact factor: 4.200

10.  Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain.

Authors:  N D Volkow; Y S Ding; J S Fowler; G J Wang; J Logan; J S Gatley; S Dewey; C Ashby; J Liebermann; R Hitzemann
Journal:  Arch Gen Psychiatry       Date:  1995-06
View more
  3 in total

Review 1.  Transcranial magnetic stimulation in the treatment of substance addiction.

Authors:  David A Gorelick; Abraham Zangen; Mark S George
Journal:  Ann N Y Acad Sci       Date:  2014-07-28       Impact factor: 5.691

2.  Methylphenidate (MPH) promotes visual cortical activation in healthy adults in a cued visuomotor task.

Authors:  Yordan Hodzhev; Juliana Yordanova; Martin Diruf; Oliver Kratz; Gunter H Moll; Vasil Kolev; Hartmut Heinrich
Journal:  J Neural Transm (Vienna)       Date:  2012-03-30       Impact factor: 3.575

3.  Methylphenidate promotes the interaction between motor cortex facilitation and attention in healthy adults: A combined study using event-related potentials and transcranial magnetic stimulation.

Authors:  Christoph Berger; Juliane Müller-Godeffroy; Ivo Marx; Olaf Reis; Johannes Buchmann; Alexander Dück
Journal:  Brain Behav       Date:  2018-11-12       Impact factor: 2.708

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.